Cafepharma Today

May 31 2023 - Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers
Sanofi sees midphase success in multiple sclerosis decades after safety concerns scuttled peers
Key FDA decisions on the horizon
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings
FDA approves Pfizer’s RSV vaccine for older adults
Stat
Wednesday, May 31, 2023 - 7:03pm
tags:
Pfizer, vaccines, FDA, elderly, RSV, Abrysvo
The Alzheimer's pipeline is as strong as ever. Now, we just need the patients
Fierce Biotech
Wednesday, May 31, 2023 - 7:02pm
tags:
Alzheimer's disease, patients, clinical trials, Biogen, Eisai, Eli Lilly
Ding Dong, Elizabeth Holmes Just Went to Prison
Motley Fool
Wednesday, May 31, 2023 - 7:00pm
tags:
Elizabeth Holmes, Theranos, fraud, prison, legal
Yuhan makes $325M cancer bet to challenge Boehringer, Takeda
Fierce Pharma
Wednesday, May 31, 2023 - 6:59pm
tags:
Yuhan, cancer, Boehringer Ingelheim, Takeda, HER2 inhbitor, non-small cell lung cancer
The Effect of Climate Change on Medical Device Manufacturing
Medical Devices and Diagnostics Industry
Wednesday, May 31, 2023 - 6:57pm
tags:
climate change, devices, Medtech, supply chain disruption
Femtech Company Hits Another Growth Catalyst
Medical Devices and Diagnostics Industry
Wednesday, May 31, 2023 - 6:55pm
tags:
Medtech, femtech, Mia procedure, breast augmentation, Establishment Labs
Biotech IPOs in 2023: Shaping the Future of Innovation
Xtalks
Wednesday, May 31, 2023 - 6:52pm
tags:
biotech, IPOs
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
BioSpace
Wednesday, May 31, 2023 - 11:15am
tags:
layoffs, Rain Oncology, Takeda, PTC Therapeutics, Affimed, Urovant Sciences, Roche, Novavax, Gossamer Bio, Bristol Myers Squibb, ADC Therapeutics
Sequoia China-Backed AI Startup Xtalpi To Partner With Pharma Giant Eli Lilly In $250 Million Novel Drug Deal
Forbes
Wednesday, May 31, 2023 - 11:12am
tags:
Eli Lilly, drug discovery, China, artificial intelligence, XtalPi
Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers
Biopharma Reporter
Wednesday, May 31, 2023 - 11:10am
tags:
vaccines, MRNA, Merck, Asia-Pacific
Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence
Biopharma Reporter
Wednesday, May 31, 2023 - 11:08am
tags:
obesity, weight loss, Novo Nordisk, Eli Lilly, Pfizer, Amgen
AbbVie's Rinvoq passes midstage test in systemic lupus erythematosus, heads into phase 3
Fierce Pharma
Wednesday, May 31, 2023 - 11:06am
tags:
AbbVie, Rinvoq, Humira, systemic lupus erythematosus, lupus, clinical trials
GE HealthCare gets FDA nod for Precision DL image processing software
Medical Device Network
Wednesday, May 31, 2023 - 11:02am
tags:
GE Healthcare, FDA, deep learning, artificial intelligence, Medtech, imaging, Precision DL
Rain Oncology to cut 65% of staff after milademetan Phase 3 trial failure
Medical Marketing and Media
Wednesday, May 31, 2023 - 11:00am
tags:
Rain Oncology, layoffs, clinical trials, milademetan, oncology, solid tumors
eXmoor pharma raises $35m to boost cell and gene therapy production
Pharmaceutical Business Review
Wednesday, May 31, 2023 - 10:58am
tags:
eXmoor pharma, funding, cell therapy, gene therapy
This Could Be Novo Nordisk's Next Big Weight-Loss Product
Motley Fool
Wednesday, May 31, 2023 - 10:56am
tags:
Novo Nordisk, weight loss, Wegovy, oral Wegovy
Sanofi sees midphase success in multiple sclerosis decades after safety concerns scuttled peers
Fierce Biotech
Wednesday, May 31, 2023 - 10:54am
tags:
Sanofi, MS, multiple sclerosis, clinical trials, frexalimab
Alzheimer’s disease market expected to reach $13.7bn across the 8MM by 2030
Clinical Trials Arena
Wednesday, May 31, 2023 - 10:53am
tags:
Alzheimer's disease
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wednesday, May 31, 2023 - 10:51am
tags:
FDA, Albireo Pharma, Aldeyra Therapeutics, Alvotech, Amneal Pharmaceuticals, Argenx, ARS Pharmaceuticals, AstraZeneca, Bayer, Bio-Thera Solutions, Biogen, BioMarin Pharmaceutical, Bristol Myers Squibb, Eisai, Eton Pharmaceuticals, F2G, Fabre-Kramer Pharmaceuticals, Fresenius, GSK, Intercept Pharmaceuticals, Ipsen, Ironwood Pharmaceuticals, Merck, Novaliq, Pfizer, Regeneron, Roche, Sanofi, Sarepta Therapeutics, Shionogi, Swedish Orphan Biovitrum, Takeda, Teva Pharmaceutica, UCB Pharma
Amylyx’s ALS drug could face rejection in Europe
BioPharma Dive
Wednesday, May 31, 2023 - 10:45am
tags:
Amylyx, ALS, EMA, Europe, Relyvrio

Pages

Latest CP Wire Articles

Eastman introduces new excipient to formulate poorly soluble API
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Klick Health launches new healthcare venture studio
Medtech earnings reports: insights from major players' Q4 results
Key compliance issues for medtech firms transitioning to data-enabled solutions
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

Latest Pharmagather Articles

Timeless
In the Pipeline
Drug Channels News Roundup, May 2023: 340B Shame, OptumRx vs. Humira Biosimilars, ICER on White Bagging, Hospitals vs. Taxes, and Dr. G
Drug Channels
AI and the Hard Stuff
In the Pipeline
Break Out the Purple Carrots
In the Pipeline
Five (or Maybe Six?) Reasons that the Largest PBMs Operate Group Purchasing Organizations
Drug Channels
Give Me Those Hard, Hard Numbers
In the Pipeline
The Top Pharmacy Benefit Managers of 2022: Market Share and Trends for the Biggest Companies
Drug Channels
What Exactly Does Ketamine Do For Depression?
In the Pipeline
PBMs and the Battle Over Patient Support Funds:Accumulators, Maximizers, and Alternative Funding (NEW Live Video Webinar)
Drug Channels

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information